AR - EGLN2

H. sapiens

SSL interaction

Identifiers

Gene Name	Gene ID	Diseases	Drugs	GO terms	Orthologs
AR	ENSG00000169083	prostate	BICALUTAMIDE DANAZOL DROMOSTANOLONE PROPIONATE ENZALUTAMIDE ETHYLESTRENOL FLUOXYMESTERONE FLUTAMIDE METHYLTESTOSTERONE NANDROLONE DECANOATE NANDROLONE PHENPROPIONATE NILUTAMIDE OXANDROLONE OXYMETHOLONE STANOZOLOL TESTOSTERONE TESTOSTERONE CYPIONATE TESTOSTERONE ENANTHATE TESTOSTERONE PROPIONATE TESTOSTERONE UNDECANOATE	RNA polymerase II core promoter proximal region sequence-specific DNA binding transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding RNA polymerase II transcription factor binding DNA binding chromatin binding transcription factor activity, sequence-specific DNA binding RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding androgen receptor activity receptor binding steroid binding androgen binding protein binding beta-catenin binding transcription factor binding zinc ion binding enzyme binding transcription regulatory region DNA binding protein dimerization activity ATPase binding POU domain binding	No GO terms in record
EGLN2	ENSG00000269858	No diseases in record	No drugs in record	protein binding ferrous iron binding oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors oxygen sensor activity L-ascorbic acid binding peptidyl-proline 4-dioxygenase activity	egl-9 (C. elegans)